METHOD OF MONITORING INTRAOCULAR PRESSURE AND TREATING AN OCULAR DISORDER

• US 20100106073A1
• Filed: 01/04/2010
• Published: 04/29/2010
• Est. Priority Date: 05/02/2001
• Status: Active Grant

• Current Assignee: Glaukos Corporation
• Original Assignee: Glaukos Corporation
• Inventors: Gharib, Morteza, Haffner, David S., Tu, Hosheng
• Granted Patent: US 8,142,364 B2
• Time in Patent Office: Days
• US Class Current: 604/8
• CPC Class Codes: A61B 3/16 for measuring intraocular pressure, e.g. tonometers
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

The invention discloses a trabecular stent and methods for treating glaucoma. The stent may incorporate an intraocular pressure sensor comprising a compressible element that is implanted inside an anterior chamber of an eye, wherein at least one external dimension of the element correlates with intraocular pressure. In some embodiments, the sensor may be coupled to the stent. Also disclosed are methods of delivery of the stent and the sensor to the eye.

Claims

1. A method of monitoring intraocular pressure, comprising:

providing a delivery device having a size of at least 20 gauge, the delivery device including a lumen extending through at least a portion thereof;

providing a sensor element configured to measure intraocular pressure and being held in the lumen of the delivery device;

forming an incision in a cornea of an eye proximate a limbal area of the eye;

inserting the delivery device through the incision into an anterior chamber of the eye;

advancing the sensor element, using the delivery device, from within the anterior chamber to eye tissue;

anchoring the sensor element to the eye tissue to measure the intraocular pressure of the eye with the sensor element being positioned completely within the anterior chamber and being exposed to aqueous humor; and

exposing the anterior chamber to a drug.

2. The method of claim 1 additionally comprising providing an implant held within the lumen of the delivery device.

3. The method of claim 2 additionally comprising positioning at least a portion of the implant in ocular tissue using the delivery device.

4. The method of claim 2 additionally comprising serially delivering the sensor element and the implant into the eye.

5. The method of claim 1, wherein anchoring the sensor element to the eye tissue comprises anchoring the sensor element to an iris of the eye.

6. The method of claim 1, wherein providing a delivery device having a size of at least 20 gauge comprises providing the delivery device with a size in the range from about 20 gauge to about 40 gauge.

7. The method of claim 1, wherein forming an incision comprises forming the incision with a sufficiently small size such that the incision is self-sealing.

8. The method of claim 1 additionally comprising positioning an implant within the eye.

9. The method of claim 8, wherein exposing the anterior chamber to a drug comprises eluting the drug from the implant.

10. The method of claim 8 additionally comprising providing the implant with a first portion and a second portion that is appended from the first portion, wherein the first portion includes a lumen and the second portion carries the drug.

11. The method of claim 8 additionally comprising providing the drug as a coating on at least a portion of the implant.

12. The method of claim 8 additionally comprising providing the drug as a coating on a biocompatible body of the implant.

13. The method of claim 8 additionally comprising providing the delivery device with at least one of the sensor element and the implant pre-loaded therein.

14. The method of claim 8 additionally comprising inserting the implant through the incision in the eye.

15. The method of claim 8 additionally comprising positioning the implant and the sensor element substantially simultaneously.

16. The method of claim 8 additionally comprising providing the sensor element in or on the implant.

17. The method of claim 8, wherein positioning an implant comprises positioning the implant in the eye such that a distal end portion of the implant extends through ocular tissue and a proximal end portion of the implant is disposed within the anterior chamber.

18. The method of claim 8 additionally comprising conducting aqueous humor through the implant from the anterior chamber to a physiologic outflow pathway of the eye.

19. The method of claim 8 positioning an implant comprises positioning the implant in the eye such that a distal end portion of the implant is disposed in a physiologic outflow pathway of the eye and a proximal end portion of the implant is disposed within the anterior chamber.

20. The method of claim 19 additionally comprising positioning the distal end portion of the implant in Schlemm'"'"'s canal.